ERBB2 and neoplasm: Three main tumor subtypes may be determined using traditional immunohistochemistry (IHC); hormone receptor (HR) positive (i.e., estrogen receptor (ER) and progesterone receptor (PR) positive), human epidermal growth factor receptor 2 (HER2) positive, and triple negative tumors.